Mediwound Ltd (MDWD) is a Healthcare · Biotechnology company listed on NASDAQ. Price $13.40 (+0.37%), Market cap $0.21B, 52-week low–high $15.05 ~ $22.24.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated i
Financial statements, price targets, institutional (13F) holdings and related news for Mediwound Ltd are updated in real time on BlackAll Trade.
Mediwound Ltd trades at $13.40 (+0.37%). Real-time quotes and charts are available on BlackAll Trade.
Mediwound Ltd has a market cap of about $0.21B.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germ